Mastrapasqua Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-30,018
Closed -$4.39M 134
2019
Q1
$4.39M Sell
30,018
-1,045
-3% -$152K 0.84% 45
2018
Q4
$4.15M Sell
31,063
-3,925
-11% -$643K 0.92% 48
2018
Q3
$6.67M Sell
34,988
-3,806
-10% -$699K 1.26% 34
2018
Q2
$6.47M Buy
38,794
+13
+0% +$2.09K 1.29% 30
2018
Q1
$6.53M Buy
38,781
+3,826
+11% +$642K 1.33% 30
2017
Q4
$5.72M Sell
34,955
-4,035
-10% -$724K 1.15% 39
2017
Q3
$7.99M Sell
38,990
-1,154
-3% -$268K 1.65% 17
2017
Q2
$9.76M Buy
40,144
+2,421
+6% +$569K 2.1% 7
2017
Q1
$9.01M Sell
37,723
-390
-1% -$90.8K 2.01% 8
2016
Q4
$8M Buy
38,113
+399
+1% +$82.7K 1.94% 12
2016
Q3
$8.69M Sell
37,714
-1,411
-4% -$345K 2.14% 9
2016
Q2
$9.04M Buy
39,125
+1,251
+3% +$288K 2.26% 10
2016
Q1
$10.2M Sell
37,874
-789
-2% -$226K 2.37% 12
2015
Q4
$12.1M Sell
38,663
-916
-2% -$273K 2.97% 4
2015
Q3
$10.8M Sell
39,579
-118
-0.3% -$36.2K 2.84% 3
2015
Q2
$12M Buy
+39,697
New +$11.8M 2.92% 3
2015
Q1
Sell
-39,482
Closed -$10.2M 127
2014
Q4
$10.2M Buy
+39,482
New +$9.87M 2.45% 5
2014
Q2
$7.18M Sell
32,180
-3,752
-10% -$777K 1.65% 21
2014
Q1
$7.4M Buy
35,932
+8,920
+33% +$1.77M 1.74% 17
2013
Q4
$4.54M Buy
27,012
+7,973
+42% +$1.25M 1.03% 41
2013
Q3
$2.74M Sell
19,039
-1,463
-7% -$195K 0.67% 55
2013
Q2
$2.59M Buy
+20,502
New +$2.32M 0.69% 50

Other funds holding AGN

Mastrapasqua Asset Management's AGN Position: Q2 2019 in Review

Mastrapasqua Asset Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 30,018 shares — an estimated $4.39M sold.

Mastrapasqua Asset Management first reported a position in AGN in Q2 2013 and held it in 22 quarters. The position peaked at $12.1M in Q4 2015. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Mastrapasqua Asset Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Mastrapasqua Asset Management sold 30,018 Allergan plc shares in Q2 2019, an estimated $4.39M.
  • Mastrapasqua Asset Management first reported a position in Allergan plc in Q2 2013 and held it in 22 quarters.
  • Mastrapasqua Asset Management's Allergan plc position peaked at $12.1M in Q4 2015.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Mastrapasqua Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.